SynBioBeta 2026
May 04th, 2026 - May 07th, 2026, San Jose
Ingenza Attendees
-
Leonardo Magneschi
VP of Research and Technology Department -
Jaymin Amin
CBO
Ingenza – a world-leading protein CRDMO – has today announced a strategic relationship with Ab Biotechnology – a MHRA‑licensed GMP facilities provider – to support the development and GMP manufacturing of innovative biotechnology products. With the companies being located and…
In this instalment of our Inside Ingenza series, Jack Kay discusses our in-house AI/ML platform, codABLE™, and how it delivers unparalleled predictability and precision when tuning protein expression compared to traditional methods.
A scientist who joined Ingenza as a 16-year-old apprentice has completed a PhD while working full-time at the company – a career path that highlights the long-term impact of work-based learning as part of Scottish Apprenticeship Week. Jack Kay, now…
Ingenza – a world-leading leading engineering biology CRDMO based in Edinburgh, Scotland – has developed GenXpress Bacillus, a powerful orthogonal protein production system. With performance comparable to the best E. coli expression systems, the new technology offers Ingenza customers a highly productive alternative that…
Ingenza Limited, a technology driven contract research, development and manufacturing organisation (CRDMO), recently welcomed Nick Challoner as its new Chief Executive Officer. Nick is a seasoned leader with more than three decades of experience in innovation, strategy and international business…
In this instalment of our Inside Ingenza series, Fraser Brown – Ingenza’s Head of Chemistry and Analytical Development – talks about a particularly complex protein we worked with.